Clinical Trials Logo

Clinical Trial Summary

Continuous radiofrequency ablation (CRF) is the effective management for cervical facet joint pain but related with neuropathic symptoms in post-radiofrequency period. Additionally, pulse radiofrequency ablation (PRF) provides relief of neuropathic symptoms. However, the effect of CRF followed by PRF has yet to be validated


Clinical Trial Description

Diagnostic procedure symptomatic facet joint was designated according to pain referral. Also, medial branches were injected with 2% lidocaine 0.3 ml per site. Treatment procedure The posterior technique was first described in 1995 . All interventions assessed the intravenous saline lock on arrival at the outpatient department using pulse oximetry and noninvasive blood pressure monitoring and intravenous sedation as required. Patients were assigned in a prone position under C-ARM fluoroscopic guidance with a Neurotherm NT 2000 Lesion Generator the (USA manufactured) . The electrode pad of the radiofrequency equipment was attached to the ipsilateral side of the posterior thigh. After the skin was then anesthetized with 1% lidocaine, a 20-gauge, 10-cm cannula with 10-mm curved active tip (Diros RF Cannula, Diros Technology Inc., Canada) was inserted along a 15 to 30 degree angle to the sagittal plane (slightly posterior oblique approach) . The cannula was applied until reaching the lateral part of the articular pillar . Then the depth of the cannula was checked using a lateral view. A probe was inserted through the cannula and linked to a radiofrequency generator (Diros Technology OWL, Canada). After impedance were accomplished at below 500 Ohm, sensory stimulation was performed at 50 Hz and the patient reported not feeling any tingling sensation along the distribution of dermatome. Consequently, a motor stimulation (2 Hz) was executed until multifidus twitching was presented at stimulation less than 1 volts and no motor twitching was observed along the myotome. A non-ionic contrast medium was injected to ensure the intravascular injection before 1% lidocaine 0.5 ml was injected after the needle reached the desired location. The study investigated two lesions due to the anatomical variation of the medial branches. Patients in the CRF group (n = 16) underwent CRF at 80°C for 90 seconds for 2 cycles. Patients in the CPRF group underwent CRF at 80°C for 90 seconds for 1 cycle followed by PRF at 42°C for 120 seconds for 1 cycle. 0.125% bupivacaine plus 2 mg of dexamethasone in a total volume of 1 mL were injected after lesioning had performed. Measurement The demographic data including age, sex, comorbidities, body mass index (BMI), level of procedure, visual analog scale (VAS;1-100) Neck Pain Disability Index and complications were reviewed. It contains ten sectors: seven sectors related to everyday existing behaviors, two sectors correlated to pain, and one sector correlated to concentration. All items are marked from 0 to 5. A mark of 0 denotes the maximum level of function, while a mark of 5 indicates the bottom level of function. The maximum mark is 50, and a greater mark relates to an increased level of disability. The NDI scores were recorded before intervention and first month, third month, sixth month, ninth months and 12 months after intervention. The follow-up was performed either face to face or by phone, and patients were not permitted to use over-the counter analgesic medication. The primary outcome was number of patients who had successful treatment, expressed as at least 80% pain relief from baseline and NDI score less than 15 for at least 3 months . The secondary outcomes comprised the duration of pain relief defined as the time of pain relief until VAS had restored to at least 50% from baseline and side effects including numbness, ataxia, dysesthesia, hypersensitivity, itching and muscular weakness (dropped head syndrome) between group comparisons. A research assistant, who was uninvolved in the intervention or post-operative follow-up, collected all data in prospective medical records. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05719948
Study type Interventional
Source Fayoum University Hospital
Contact
Status Completed
Phase N/A
Start date October 1, 2020
Completion date February 1, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04420013 - Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIon
Completed NCT02382289 - Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points N/A
Terminated NCT06371716 - Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions N/A
Terminated NCT03247413 - Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation Phase 4
Recruiting NCT06033456 - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome N/A
Not yet recruiting NCT05559073 - Outcomes of Early Referral to Radiofrequency Ablation in Symptomatic Atrial Fibrillation Patients.
Completed NCT05078541 - Radiofrequency Ablation for Warthin's Tumor N/A
Recruiting NCT06003218 - Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation N/A
Recruiting NCT05500703 - Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia Phase 4
Completed NCT03375281 - Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique N/A
Recruiting NCT05142904 - Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules Phase 3
Recruiting NCT00750711 - Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters N/A
Recruiting NCT02793479 - Radiofrequency Ablation in Patients With Barrett's Esophagus
Completed NCT01091597 - Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation N/A
Not yet recruiting NCT04417010 - To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
Recruiting NCT03067493 - RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial Phase 2
Recruiting NCT04471272 - RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes N/A
Recruiting NCT04842253 - HFNC vs LFNC in Patients With AF Undergoing RFCA Under Deep Sedation. N/A
Completed NCT04801719 - Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis N/A
Recruiting NCT04331184 - RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes N/A